Status:
NOT_YET_RECRUITING
Changes in Natural Immunity in Pregnant Women With Autoimmune Thyroid Disease
Lead Sponsor:
University of Rijeka
Conditions:
Pregnancy
Autoimmune Thyroid Disease
Eligibility:
FEMALE
18-45 years
Brief Summary
Autoimmune thyroid disease (AITD) is the most common endocrine disorder in women of reproductive age, including during pregnancy. It encompasses two clinical conditions: autoimmune hyperthyroidism and...
Detailed Description
Autoimmune thyroid disease (AITD) affects approximately 2-17% of women of reproductive age, and represents the most common endocrine disorder in pregnancy. It includes autoimmune hyperthyroidism and h...
Eligibility Criteria
Inclusion
- adult healthy pregnant women and pregnant women with autoimmune thyroid disease
- with a single pregnancy
- older than 18 years
- who have signed the informed consent form
Exclusion
- pregnant women who refuse to give informed consent
- pregnant women under the age of 18
- pregnant women with malignant diseases
- pregnant women with thyrotoxicosis or hypothyroidism of a non-autoimmune nature and previous thyroidectomy or ablative therapy with iodine-131
- pregnant women with an acute or chronic disease that is not an autoimmune thyroid disease
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06925399
Start Date
May 1 2025
End Date
May 1 2027
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine University of Rijeka, Clinical Hospital Center Rijeka
Rijeka, Primorsko-goranska County, Croatia, 51000